Clinical Trials Browser

Phase 3 × Classical hematology × 30 days × Clear all

NCT07410117 2026-05-27

ROXI-CAT-I

Phase 3 Recruiting

Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT06499285 2026-05-13

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Phase 3 Recruiting

Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes